2014 पीएफएस फाउंडेशन वार्षिक पता

Aug. 4, 2014 Dear Friends: I’m pleased to report that 2014 is shaping up to be a turning point on the road to widespread awareness of post-finasteride syndrome. Couple that with the steady progress of our clinical studies and I become ever more hopeful that the coming year will bring not only worldwide acceptance of […]

पोस्ट-फ़ाइनस्टराइड सिंड्रोम का क्लिनिकल अध्ययन बायलर कॉलेज ऑफ़ मेडिसिन में शुरू किया गया

SOMERSET, N.J., Aug. 21, 2013 – The Post-Finasteride Syndrome Foundation today announced the funding of a second major clinical study on post-finasteride syndrome (PFS), this one at Baylor College of Medicine (BCM) in Houston, Texas. Titled “Genetic and Epigenetic Studies on Post-Finasteride Syndrome Patients,” the research is being led by Mohit Khera (right), MD, MBA, […]

ब्रिघम और महिला अस्पताल में पोस्ट-फ़ाइनस्टराइड सिंड्रोम का नैदानिक अध्ययन शुरू किया गया

SOMERSET, N.J., July 1, 2013 – The Post-Finasteride Syndrome Foundation today announced the funding of a major clinical study on post-finasteride syndrome (PFS) at Brigham and Women’s Hospital (BWH), a teaching affiliate of Harvard Medical School. Titled “A Preliminary, Hypothesis-Generating Investigation of the Post-Finasteride Syndrome: Description of the Phenotype, and Elucidation of the Hormonal, Genetic […]

फरवरी 2013 से सार इटली में पीएफएस गोलमेज अनुसंधान चर्चा

SOMERSET, N.J., March 25, 2013 – The roundtable discussion at the 7th international steroids and nervous system meeting in Orbassano (TO), Italy, February 16th – 20th 2013, included scientific presentations and discussions amongst multiple medical researchers regarding the Post-Finasteride Syndrome. This event was a great opportunity for the PFS Foundation to increase awareness of PFS […]

पोस्ट-फ़ाइनस्टराइड सिंड्रोम फाउंडेशन एक सार्वजनिक धर्मार्थ के रूप में आईआरएस द्वारा दी गई गैर-लाभकारी स्थिति है

SOMERSET, N.J., March 18, 2013 – The Post-Finasteride Syndrome Foundation today announced that it has been granted 501(c)(3) status by the Internal Revenue Service. “Nonprofit status will allow us to put more dollars to work pursuing our core goal, which is funding research on the characterization, underlying biologic mechanisms and treatments of PFS,” added Dr. […]

विनियामक अद्यतन: जर्मनी का एफडीए समतुल्य मुद्दे ‘रेड हैंड लेटर’ फिनस्टराइड एडीआर पर

July 6, 2018 Dear Friends: Apparently heeding an appeal by Germany’s largest weekly newspaper, the Federal Institute for Drugs and Medical Devices (BfArM) has dispatched a so-called Red Hand Letter to doctors and pharmacists nationwide, informing them of severe and persistent adverse drug reactions (ADRs) to finasteride. Five months ago, we told you that Die […]

‘हम यह अनुशंसा नहीं करेंगे कि कोई भी आदमी ले ‘फ़ाइटरसाइड, विश्वविद्यालय अस्पताल में मूत्र रोग विशेषज्ञ ज्यूरिख टीवी टीवी पत्रिका

May 20, 2018 Dear Friends: Yet another European nation has taken to the airwaves with PFS awareness. This time it’s Switzerland. The network is Swiss Radio and Television (SRF). And the program is Puls. On May 7, the weekly health-news magazine debuted a special report titled Do Anti-Baldness Remedies Make You Impotent? (English-subtitled version here.) […]

पीएफएस और पोस्ट-एसएसआरआई यौन रोग के बीच आम रास्ते दोनों के लिए चिकित्सीय रणनीतियों को डिजाइन करने में उपयोगी हो सकते हैं, मिलानो अध्ययन के नए विश्वविद्यालय कहते हैं

April 30, 2018 Dear Friends: Roberto Cosimo Melcangi, Ph.D., head of the Neuroendocrinology Unit in the Department of Pharmacological and Biomolecular Sciences at the University of Milano, has published a new paper in the current issue of Endocrine: International Journal of Basic and Clinical Endocrinology. Titled Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of […]

पीएफएस पर मरीजों को बेहतर शिक्षित डॉक्टरों के लिए संघीय संस्थान पर जर्मन पेपर कॉल का नेतृत्व करना

March 12, 2018 Dear Friends: PFS is a growing concern in Germany, too. Ditto Albania. In December, we told you that the French National Agency for Drug Safety (ANSM) launched a public-awareness campaign warning against reported mood changes in Propecia patients, “particularly depression, and suicidal ideation.” Now we’re encouraged to report that Die Zeit, Germany’s […]